World FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis – Contract Pharma Last updated: April 14, 2026 9:31 pm Editorial Staff 7 months ago Share SHARE FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis Contract Pharmasource Grant Turner (’25): Impacting International Affairs – The Institute of World Politics Iran wants team members who served in the Revolutionary Guard to get visas for the World Cup – AP News VIDEO: King County's World Cup travel plan – KIRO 7 News Seattle China aims to show global leadership with Iran war diplomacy. US appears uninterested – WRAL Iran live updates: Trump's 'Project Freedom' to begin Monday amid attacks in strait – ABC News – Breaking News, Latest News and Videos Share This Article Facebook Email Print Previous Article Trump again rejects Colorado amid accusations of playing politics with disaster aid – Newsday Next Article Times Opinion: Vaccine confusion sets up US for a resurgence of hepatitis B in babies – Chattanooga Times Free Press Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
